www.benitec.com/documents/IntersuiiseAug07/pdf - interest read for anyone who has not done so already includes Nucleonics twice failing in court re patent challenges to date - so here's hoping for a third. Interesting analyst said more licensing pharma deals then more likely BLT's success so Pfizer ann good news. Wait and see latest Nucleonics appeal amend outcome I guess and phase 1 HIV trial outcomes expected end of 1st quarter apparently.
Cheers
BLT Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
